spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

Connectivity, customization and sustainability driving packaging and drug delivery in 2020

Pharmapack

Pharmapack 2020 gathering top specialists and pioneers to exchange their vision on best strategies to tackle key challenges

Paris, 03 December 2019: Connectivity, customization and sustainability are driving pharmaceutical packaging and drug delivery innovation at Pharmapack Europe (#pharmapackeu), which opens in February 2020. The event is the leading exhibition dedicated to pharmaceutical packaging and drug delivery devices, with major industry players set to come together to discuss vital best practices, insights and strategies.

“This year’s Pharmapack Europe agenda highlights what an interesting time it is for packaging and drug delivery, showcasing the full depth and breadth of developments anticipated in the upcoming year,” says Silvia Forroova, Brand Director at Pharmapack Europe. “Most excitingly, our speakers feature some of the industry’s most prominent experts, leading pharma companies and new start-ups delivering tomorrow’s vital innovations. Pharmapack Europe is a content-rich experience and the premier business platform for executives looking for new partners to drive forward tomorrow’s approaches in drug delivery and packaging”.

Pharmapack Europe will host four themed conference sessions and a number of educational and interactive workshops and learning labs, with the event featuring more than 45 unique sessions, including keynotes from leading pharma companies, promising start-ups and knowledge partners.

The connectivity and patient-centricity session will explore the effects of digitalization and disruptive technologies on packaging and drug delivery devices, and includes Aurelio Arias, Senior Consultant, European Thought Leadership, IQVIA speaking on “Digital Value-Added Medicines”.

In another highly anticipated session on sustainability, speakers will assess eco-friendly and energy-efficient packaging with the goal of reducing life-cycle and environmental impact. Fabien Thibault and Corinne Ondo of Merck Group will put forward their company’s strategies for improving packaging sustainability by adopting the use of recyclable materials, while also cutting down on energy, space, and overall material usage in packaging production.

Within the Challenges in Drug Delivery for Biologics session, the focus will be on how companies are developing advanced delivery technologies to cater for the greater sensitivity of biologic drugs.

The ‘New Horizons in Innovation’ session will address the challenge in bridging the development gap between clinical and commercial applications as more innovators come to market, and how scale-up challenges will continue to present a significant barrier for the industry to overcome in order to fully reach its potential. This session also features the Pharmapack Awards 2020 winners’ presentation.

Several Learning Lab workshops will also be held throughout the two-day event, covering a breadth of topics within pharmaceutical packaging and drug delivery – from the impact of medical device regulation in the industry and polycarbonate innovations for novel drug delivery devices to an evaluation of current and future delivery strategies.

These workshops will provide attendees ample opportunity to interact with exhibitors on a more personal level and gain insight into industry trends that are of most relevance. They will include practical examples from specialists such as Haselmeier, Aptar, Graphic West Biocorp and others.

Finally, entries for the 2020 Pharmapack Awards are now open across both the ‘Exhibitor Innovation’ and ‘Health Products’ categories, with a closing date of 6th November 2019. The Health Products category will include two winners with one for Patient-Centric Design – which is launched in partnership with HCPC Europe (Healthcare Compliance Packaging Council of Europe) – and a second introduced alongside Adelphe and HPRC (Healthcare Plastics Recycling Council) for Eco-design in health packaging and drug delivery devices.

The event will be held at the Porte De Versailles in Paris (5-6 February, 2020) and is the leading hub for stakeholders across all parts of the pharmaceutical packaging and drug delivery supply chain, with over 5300 attendees and 400+ exhibitors from 75 countries expected to be present.
phone +31(0)20 708 1637
email https://www.pharmapackeurope.com/
email Paris Expo, Porte de Versailles - Hall 7.2 | Paris, France
 
Print this page
Send to a friend
   
spacer
News and Press Releases

A new anti-tumour treatment is one step closer to the clinic thanks to a new collaboration between In3Bio and 3P Biopharmaceuticals

[Pamplona, November 26 2019] 3P Biopharmaceuticals, a leading Contract Development and Manufacturing Organization (CDMO) specialized in process development and cGMP manufacturing of biologics, has been chosen by In3Bio, a UK based Biotech company, to collaborate in the development of a novel anti-tumour treatment.
More info >>


White Papers

Is Your Biobank Ready for the Challenge of Biomarker-based Research?

BioFortis

Targeted and personalized studies with well-defined patient segmentation biomarkers are becoming the norm in clinical trials. This increased interest in molecular biomarker studies necessitates a rigor and sophistication in sample management within the clinical trial context that is often not supported either by traditional clinical trial management software (CTMS), or biobanking systems.  Download our Next Generation Biobanking whitepaper and learn about how to overcome the key challenges in clinical trial sample management from working in a distributed network of partners and stakeholder to managing consents and generating scientific insights.
More info >>

Industry Events

BioTrinity 2020

28-29 April 2020, Digitally delivered

BioTrinity is a long-running and highly regarded two day life sciences conference that takes place in Central London from 28-29 April. BioTrinity focuses on partnering, investment and collaboration and aims to inspire growth and create opportunities for all who attend. The core delegate mix includes early-stage and emerging biotech, medtech and digital health companies, big pharma executives and life sciences investors.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement